pretickt

Henry Schein, Inc. (HSIC)

Healthcare · end-of-day data as of Oct 16, 2026

Henry Schein, Inc.
HSIC · $9.63B
$86.38+1.1%last 60 sessions · close Oct 16, 2026
$62.03$90.8652 weeks
Buy · 16 analystsPT $91.57 +6.0%
  • P/E vs own+11.0%
  • P/E vs sector-10.6%
  • Target upside+6.0%
  • Off 52w high-4.9%
  • InsidersNone in 90d
  • FCF yield+5.6%
  • Earnings in18d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI53
  • MA20×50—
  • Volume1.0x
  • Support-3.8%
  • Resistance+2.3%

The average 12-month analyst price target for HSIC is $91.57, 6.0% above the last close of $86.38 on Oct 16, 2026; targets range from $63.44 to $108.39. Rating consensus: Buy.

Snapshot

  • P/E25.2x
  • P/E vs sector-10.6%
  • P/E vs own+11.0%
  • Target upside+6.0%
  • ConsensusBuy
  • Market cap$9.63B
  • FCF yield+5.6%
  • InsidersNone in 90d
  • Earnings in18d
  • News0.00

Why it moved

Henry Schein, Inc. (HSIC) fell 0.7% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.

Market (SPY)-1.1%
Healthcare sector+0.4%
HSIC specific0.0%

0 stories on the day (30-day average 0.4).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$63.90$72.26$80.63$88.99Oct 25Jan 26Apr 26Jul 26Oct 26EAEEAEE

Last close $86.38 · +39.3% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendsideways
  • Sector▲ +16.0%
  • MAs20▲ 50▼ 100▲ 200▲
  • Above MAs3 of 4 above
  • MA20×50—
  • RSI53
  • Support-3.8%
  • Resistance+2.3%
  • Off 52w high-4.9%
  • Off ATH-6.1%
  • 52w range$86.38
  • Bollingerupper half
  • MACD0.33
  • ATR+2.3%
  • Volume1.0x

Analyst price targets

Low$63.44
Average$91.57
Median$94.48
High$108.39
Upside+6.0%

11 firms with a target in the last 12 months · last close $86.38 · as of Oct 16, 2026

⇔⇕$59.71$72.46$85.21$97.96$111Oct 25Mar 26Aug 26Jan 27Jun 27-1%+2%+17%-27%+4%+10%+21%+7%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 4 · Buy 4 · Hold 7 · Sell 1 · Strong sell 0

Revenue and free cash flow

Q2 FY2026: Revenue +6.7% year over year, free cash flow 5.7% of revenue, operating margin 5.8%.

RevenueFree cash flow
Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Q2 FY2026Jun 27, 2026$3.46B0.82$196M31.8%5.8%2.7%
Q1 FY2026Mar 28, 2026$3.37B0.92-$136M31.8%5.4%3.2%
Q4 FY2025Dec 27, 2025$3.44B0.85$338M28.9%5.4%2.9%
Q3 FY2025Sep 27, 2025$3.34B0.84$141M28.7%6.2%3.0%
Q2 FY2025Jun 28, 2025$3.24B0.70$88M29.4%5.4%2.7%
Q1 FY2025Mar 29, 2025$3.17B0.88-$6M29.6%6.4%3.5%
Q4 FY2024Dec 31, 2024$3.19B0.74$159M29.1%6.0%2.9%
Q3 FY2024Sep 28, 2024$3.17B0.78$117M29.3%6.5%3.1%

Peers

20D
1MCKMcKesson Corporation$1,004.84+0.6%0.0%-1.5%26.9$117B
2CORCencora, Inc.$340.92-0.1%-8.5%+6.8%25.3$65.06B
3CAHCardinal Health, Inc.$254.06+0.1%0.0%+4.5%35.1$58.83B
4COOThe Cooper Companies, Inc.$57.94+0.9%-31.3%+0.9%19.8$11.02B
5UHSUniversal Health Services, Inc.$185.10-1.2%-23.9%+11.1%7.6$10.91B
6ALGNAlign Technology, Inc.$147.31-1.4%-25.4%+35.1%25.6$10.46B
7PODDInsulet Corp.$141.10+1.7%-59.3%+32.3%26.4$9.79B
8HSICHenry Schein, Inc.$86.38-0.7%-4.9%+6.0%25.2$9.63B

Data as of Oct 16, 2026 close.

Latest news

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.